We would love to hear your thoughts about our site and services, please take our survey here.
what a ******. totally disdain.
just looked first time today since a **** morn, blimey, what the heck. so so exciting and deserved, more for you all as i’m more passive but so so happy to be involved.
congrats to you all for the now inevitable. just on the cusp.
WE could end up being the big Pharma Yeboha. Let’s start taking the revenue and keep it growing rapidly on the back of game changing science. So much more to develop having now unlocked the path for the future.
Never in doubt! Outstanding news today. Congrats to everyone involved.
Looks like it’s on all the way and options galore on the ways forward.
I can now appreciate that it was far better for the full progress story to be uncovered through the science day, as it has been done. It would have been tricky to release such complex data in an RNS which could have been open to overreaction and chains of interpretation.
The debrief has been thorough, unambiguous and extremely well presented. It’s been handled with delicacy and due care.
I’m also even more mindful of those patients who have taken part with little prospect of the trial affecting their outcome and through their actions, have cleared a path for those in the next stage, who do have a far greater chance of benefitting.
Whilst the trial team have no doubt been excited by the science and the results to date, it must have been a sombre rapport with patients they’ve interacted with during the trial.
The progress presented looks as good as anyone could have hoped for and presents real prospect now of going all the way. Quite incredible.
I'm a bit confused why yesterday's RNS said ''No material new information will be disclosed as part of this meeting''.
The data on P84 and P85 seems pretty material to me and goes much further than ''meaningful'' amounts found in tumor biopsies.
It’s a ballsy mission statement. Whatever may come out of tomorrow, or soon after, there’s going to be quite an epiphany when more detail is disclosed.
GLA all, big times ahead.
The last update and the video were superb. There was nothing vague and all that we need to consider our investment. This is massive and once it progresses through the next stage will redefine what the meaning of ‘disruptive’ is. In my opinion it may not be acquirible.
Solid gains and hugely exciting to see such a steady move. It is a pittance though considering the clinical breakthrough that’s in the public domain. One can only imagine where we end up once this is in mainstream media and the true realisation of the achievement. I guess it’s going to be a complex one to handle for the big industry community- how a tiny Company has brought this game changer close to reality and who is going to stump up a fortune to buy in or even attempt to acquire.
Congrats to all.
Def stick. Never get a chance like it again, to be part of something so special. Loads of valuation scenarios should be thrown out of the window if this continues to progress in the way it’s going. It’s not pie in the sky, need to remind ourselves this is happening and there are likely to be more funding/expansive plays under the bonnet than are apparent at the moment.
Not a cat in hells. The problem with Avacta is no one can afford to buy it. The disruption is a problem and the cost to acquire is an even bigger problem. It’s worth a fortune and should be seen as that and held long term.
In my opinion, by far the best interview delivered by him. No Re-assurance required or grey areas or any doubts. Really like the US sites being brought into the picture aswell.
Down to fine tuning now.
Was a wonderful week and the best possible, long awaited news was well delivered. Congrats all and have a great weekend.
It makes complete sense to focus further on dose levels. Greater clarity on this will provide so much for the next phase and increase the scale of the treatment opportunity. All came across so well in the Vox audio. Great job.
Indeed. No other way of seeing it, today was a game changer. No grey areas and ambiguity.
and the amazing thing about the remainder of the trial is that it’s about how wells and not ifs. The ongoing perfecting and data gathering is only likely to reveal further opportunity and scope rather than whether it gets a green light.
The mind boggles, I need a drink!
Haven’t heard such an excited tone from Al in a long time, he’s bouncing off the walls, as he should be.
Means a lot hearing the news backed up by audio. Bodes well for a huge science day aswell.
We can only sit back now and watch the staggering ongoing story unfold. Neil Armstrong eat your heart out :)
Huge congrats all. I’m still shaking from this incredible morning.
Been offline, only just seen the RNS, WOW is all I can say, just bloody WOW.
Incredible achievement Avacta team and thanks Al for the update :) we got the full Monty in the end.
Can’t stop thinking where this goes from here. Endless opportunities and USA orphan etc will fly.
There will be a steady stream of amazing developments on the back of this and a Company worth an eye watering fortune.
Well done to everyone.
I’m getting the feeling that the ‘update’ slight delay is because we will now be given some compelling data aswell. No doubt they have it all, most likely decided that, having read through the draft update and what is in hand, they’ve decided why not send out fully loaded instead. That would have taken quite some checking over, rather than a blander update RNS.
Thanks for sharing. Smart-looking doc with aggressive timelines. It looks like it's going places quickly and highly investible.